(1s,3'r,6'r,7's,8'e,11's,12'r)–6–כלורו–7'–מתוקסי–11',12'–דימתיל–4,3–דיהידרו–2h,15'h–ספירו[נפתלן–22',1–[20]אוקסא[13]תיא[14,1]דיאזאטטראציקלו[14.7.2.03,6.019,24]פנטאקוסא[24,18,16,8]טטראין]–15'–און–13',13'–דיאוקסיד לשימוש כתרופה
Provided herein are intermediates that are useful in methods for producing myeloid cell leukemia 1 protein (Mcl-1) inhibitors of Formula (I), and methods for the preparation of the myeloid cell leukemia 1 protein (Mcl-1) inhibitors using the intermediates. The compounds of formula (I) and compositions comprising them may be used, for example, in the treatment of diseases or conditions, such as cancer.
